| 680058 |
FRONTIERS IN ONCOLOGY |
Characteristics of Pan-Cancer Patients With Ultrahigh Tumor Mutation Burden |
2021-04-22 |
10.3389/fonc.2021.682017 |
Yuan Hong, Ji Jun, Shi Min, Shi Yan, Liu Jing, Wu Junwei, Yang Chen, Xi Wenqi, Li Qingyuan, Zhu Wei, Li Jingjie, Gong Xiaoli, Zhang Jun |
| 680057 |
FRONTIERS IN ONCOLOGY |
Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer |
2021-04-22 |
10.3389/fonc.2021.650453 |
Zhao Yunchun, Zheng Xiaoling, Zheng Yongquan, Chen Yue, Fei Weidong, Wang Fengmei, Zheng Caihong |
| 680056 |
FRONTIERS IN ONCOLOGY |
Cryptotanshinone Inhibits ERα-Dependent and -Independent BCRP Oligomer Formation to Reverse Multidrug Resistance in Breast Cancer |
2021-04-22 |
10.3389/fonc.2021.624811 |
Ni Wenting, Fan Hui, Zheng Xiuqin, Xu Fangming, Wu Yuanyuan, Li Xiaoman, Wang Aiyun, Huang Shile, Chen Wenxing, Wang Shijun, Lu Yin |
| 680055 |
FRONTIERS IN ONCOLOGY |
Laparoscopic vs. Open Repeat Hepatectomy for Recurrent Liver Tumors: A Propensity Score–Matched Study and Meta-Analysis |
2021-04-22 |
10.3389/fonc.2021.646737 |
Chen Jia-Feng, Fu Xiu-Tao, Gao Zheng, Shi Ying-Hong, Tang Zheng, Liu Wei-Ren, Zhang Xin, Gao Qiang, Ding Guang-Yu, Song Kang, Wang Xiao-Ying, Zhou Jian, Fan Jia, Ding Zhen-Bin |
| 680054 |
FRONTIERS IN ONCOLOGY |
p53 Expression, Programmed Death Ligand 1, and Risk Factors in Urinary Tract Small Cell Carcinoma |
2021-04-22 |
10.3389/fonc.2021.651754 |
Golijanin Borivoj, Gershman Boris, De Souza Andre, Kott Ohad, Carneiro Benedito A., Mega Anthony, Golijanin Dragan J., Amin Ali |
| 680053 |
FRONTIERS IN ONCOLOGY |
Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice |
2021-04-22 |
10.3389/fonc.2021.657639 |
Roberto Michela, Botticelli Andrea, Panebianco Martina, Aschelter Anna Maria, Gelibter Alain, Ciccarese Chiara, Minelli Mauro, Nuti Marianna, Santini Daniele, Laghi Andrea, Tomao Silverio, Marchetti Paolo |
| 680052 |
FRONTIERS IN ONCOLOGY |
Case Report: Primary Extraskeletal Osteosarcoma in the Lung and Pulmonary Artery |
2021-04-22 |
10.3389/fonc.2021.673494 |
Zhai Duchang, Cai Wu, Fan Guohua, Yang Junlin, Liu Chenchen |
| 680051 |
FRONTIERS IN ONCOLOGY |
A Combined Prediction Model for Lymph Node Metastasis Based on a Molecular Panel and Clinicopathological Factors in Oral Squamous Cell Carcinoma |
2021-04-22 |
10.3389/fonc.2021.660615 |
Wang Shu, Li Tiancheng, Liu Huan, Wei Wei, Yang Yang, Wang Chong, Li Bo, Han Zhengxue, Feng Zhien |
| 680050 |
FRONTIERS IN ONCOLOGY |
Commentary: Overall Survival in Heart Disease–Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study |
2021-04-22 |
10.3389/fonc.2021.639042 |
Jiao Yiping, Qian Chengqi, Fei Shumin |
| 680049 |
FRONTIERS IN ONCOLOGY |
Case Report: Outcome of Osimertinib Treatment in Lung Adenocarcinoma Patients With Acquired KRAS Mutations |
2021-04-22 |
10.3389/fonc.2021.630256 |
Xiu Weigang, Zhang Qianqian, Yu Min, Huang Yin, Huang Meijuan |
